The Surprising Surge in One-Time Titans and the Weight-Loss Drugmaker at All-Time Highs 3/29/23
CNBC's "Fast Money"
00:00
The Surgeon Anti-Obesity Drugs: Good Things Are Coming for Other Big Therapeutics Developers
Long term, the addressable market here is huge. It's going to take a while to get there, especially as we need an insurance to cover it. I think for that reason, I would look at some of your other pharmaceuticals like you pointed out,. Lily, which has a much better diversified revenue source.
Play episode from 33:18
Transcript
